Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Minoxidil may help treat hair loss by reducing inflammation-related gene activity in skin cells.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Ajwain seed extract improved skin healing and hair growth in a mouse skin irritation model.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

IL-1β inhibits human hair follicle growth.

Interleukin 6 helps hair grow.

Salivary vitamin D and IL-6 could help diagnose and manage non-scarring alopecia.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Certain gene variations are linked to alopecia areata.

Patients with Alopecia Areata have higher levels of certain inflammatory markers.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.